A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

611

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

CP-690,550

5mg CP-690,550 BID PO for 6 months

DRUG

CP-690,550

10 mg CP-690,550 BID PO for 6 months

DRUG

Placebo

Placebo patients advance to 5mg CP-690,550 BID at Month 3 visit

DRUG

Placebo

Placebo patients advance to 10mg CP-690,550 BID at Month 3 visit

Trial Locations (95)

1008

Pfizer Investigational Site, Manila

1606

Pfizer Investigational Site, Sofia

1709

Pfizer Investigational Site, Sofia

1742

Pfizer Investigational Site, Las Piñas

4000

Pfizer Investigational Site, Plovdiv

4002

Pfizer Investigational Site, Plovdiv

4114

Pfizer Investigational Site, Dasmariñas

5800

Pfizer Investigational Site, Pleven

8000

Pfizer Investigational Site, Bajada, Davao City

12206

Pfizer Investigational Site, Albany

14059

Pfizer Investigational Site, Berlin

14618

Pfizer Investigational Site, Rochester

14760

Pfizer Investigational Site, Olean

16635

Pfizer Investigational Site, Duncansville

18015

Pfizer Investigational Site, Bethlehem

21018

Pfizer Investigational Site, Vinnitsa

21702

Pfizer Investigational Site, Frederick

22010

Pfizer Investigational Site, Tijuana

22081

Pfizer Investigational Site, Hamburg

26301

Pfizer Investigational Site, Clarksburg

27103

Pfizer Investigational Site, Winston-Salem

27803

Pfizer Investigational Site, Rocky Mount

28210

Pfizer Investigational Site, Charlotte

29572

Pfizer Investigational Site, Myrtle Beach

29601

Pfizer Investigational Site, Greenville

31000

Pfizer Investigational Site, Chihuahua City

32216

Pfizer Investigational Site, Jacksonville

33542

Pfizer Investigational Site, Zephyrhills

33614

Pfizer Investigational Site, Tampa

34233

Pfizer Investigational Site, Sarasota

34292

Pfizer Investigational Site, Venice

44620

Pfizer Investigational Site, Guadalajara

45408

Pfizer Investigational Site, Dayton

46150

Pfizer Investigational Site, Petaling Jaya

49048

Pfizer Investigational Site, Kalamazoo

58701

Pfizer Investigational Site, Minot

61107

Pfizer Investigational Site, Rockford

61178

Pfizer Investigational Site, Kharkiv

62250

Pfizer Investigational Site, Putrajaya

64020

Pfizer Investigational Site, Monterrey

71913

Pfizer Investigational Site, Hot Springs

75150

Pfizer Investigational Site, Mesquite

75231

Pfizer Investigational Site, Dallas

79011

Pfizer Investigational Site, Lviv

80336

Pfizer Investigational Site, München

85234

Pfizer Investigational Site, Gilbert

85704

Pfizer Investigational Site, Tucson

88586

Pfizer Investigational Site, Kota Kinabalu

90429

Pfizer Investigational Site, Nuremberg

93586

Pfizer Investigational Site, Kuching

95017

Pfizer Investigational Site, Simferopol, Crimea

98104

Pfizer Investigational Site, Seattle

98122

Pfizer Investigational Site, Seattle

185019

Pfizer Investigational Site, Petrozavodsk

214019

Pfizer Investigational Site, Smolensk

575002

Pfizer Investigational Site, Mangalore

7510186

Pfizer Investigational Site, Santiago

7530206

Pfizer Investigational Site, Providencia

8360156

Pfizer Investigational Site, Santiago

02763

Pfizer Investigational Site, Hyannis

07666

Pfizer Investigational Site, Teaneck

19611-1124

Pfizer Investigational Site, West Reading

74110-120

Pfizer Investigational Site, Goiânia

80060-240

Pfizer Investigational Site, Curitiba

22271-100

Pfizer Investigational Site, Rio de Janeiro

90035-003

Pfizer Investigational Site, Porto Alegre

90035-903

Pfizer Investigational Site, Porto Alegre

90610-000

Pfizer Investigational Site, Porto Alegre

04266-010

Pfizer Investigational Site, São Paulo

05437-010

Pfizer Investigational Site, São Paulo

Unknown

Pfizer Investigational Site, Bucaramanga

Pfizer Investigational Site, Barranquilla

625 00

Pfizer Investigational Site, Brno

470 01

Pfizer Investigational Site, Česká Lípa

748 01

Pfizer Investigational Site, Hlučín

530 02

Pfizer Investigational Site, Pardubice

128 50

Pfizer Investigational Site, Prague

140 00

Pfizer Investigational Site, Prague

140 59

Pfizer Investigational Site, Prague

760 01

Pfizer Investigational Site, Zlín

00000

Pfizer Investigational Site, Santo Domingo

06108

Pfizer Investigational Site, Halle

04103

Pfizer Investigational Site, Leipzig

500 004

Pfizer Investigational Site, Hyderabad

500 003

Pfizer Investigational Site, Secunderabad

380 015

Pfizer Investigational Site, Ahmedabad

560 001

Pfizer Investigational Site, Bangalore

560 034

Pfizer Investigational Site, Bangalore

560 079

Pfizer Investigational Site, Bangalore

575 001

Pfizer Investigational Site, Mangalore

411 001

Pfizer Investigational Site, Pune

02-256

Pfizer Investigational Site, Warsaw

50-088

Pfizer Investigational Site, Wroclaw

00918

Pfizer Investigational Site, San Juan

04114

Pfizer Investigational Site, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00814307 - A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter